Literature DB >> 18609737

Psoriatic arthritis screening tools.

Abrar A Qureshi1, Patrick Dominguez, Kristina C Duffin, Dafna D Gladman, Philip Helliwell, Philip J Mease, M Elaine Husni.   

Abstract

Psoriatic arthritis (PsA) is an inflammatory arthritis associated with psoriasis, with an indolent and progressive course. A delay in diagnosis and treatment may lead to an erosive arthropathy, leading further to physical disability and deformity. To help clinicians screen for PsA, the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) has led an effort to develop and validate 3 PsA screening tools. Administration of a well designed screening tool can increase detection of PsA, help determine the prevalence of PsA in a given population, record clinical data for genotype-phenotype studies, and track response to therapy. The development and validation of these screening tools was a major focus at the GRAPPA annual meeting at Boston in September 2007; we summarize that portion of the meeting.

Entities:  

Mesh:

Year:  2008        PMID: 18609737

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  12 in total

1.  Smoking and risk of incident psoriatic arthritis in US women.

Authors:  Wenqing Li; Jiali Han; Abrar A Qureshi
Journal:  Ann Rheum Dis       Date:  2011-11-08       Impact factor: 19.103

2.  [Treatment recommendations for psoriatic arthritis].

Authors:  W-H Boehncke
Journal:  Z Rheumatol       Date:  2009-12       Impact factor: 1.372

Review 3.  Application of the GRAPPA psoriatic arthritis treatment recommendations in clinical practice.

Authors:  Aizad Mumtaz; Oliver FitzGerald
Journal:  Curr Rheumatol Rep       Date:  2010-08       Impact factor: 4.592

4.  Which Psoriasis Patients Develop Psoriatic Arthritis?

Authors:  Kristine Busse; Wilson Liao
Journal:  Psoriasis Forum       Date:  2010

5.  Clinical features of psoriatic arthritis in Korean patients with psoriasis: a cross-sectional observational study of 196 patients with psoriasis using psoriatic arthritis screening questionnaires.

Authors:  Dongyun Shin; Hee Joo Kim; Dae Suk Kim; Soo Min Kim; Jin Su Park; Yong-Beom Park; Min-Geol Lee
Journal:  Rheumatol Int       Date:  2015-09-22       Impact factor: 2.631

6.  Validation of Sinhala version of Psoriasis Epidemiology Screening Tool.

Authors:  Achala Liyanage; S Verni; G Liyanage; V De Silva; J Akarawita; C Gunasekera; J Rubasinghe; S Imafuku; S Lekamwasam
Journal:  Clin Rheumatol       Date:  2021-02-16       Impact factor: 2.980

7.  Validity, reliability, and sensitivity-to-change properties of the psoriatic arthritis screening and evaluation questionnaire.

Authors:  Patrick Lee Dominguez; M Elaine Husni; Elizabeth W Holt; Stephanie Tyler; Abrar A Qureshi
Journal:  Arch Dermatol Res       Date:  2009-07-15       Impact factor: 3.017

8.  Validation of the Toronto Psoriatic Arthritis Screen II (TOPAS II) questionnaire in a Turkish population.

Authors:  Mehmet Tuncay Duruöz; Canan Şanal Toprak; Fırat Ulutatar
Journal:  Rheumatol Int       Date:  2017-11-07       Impact factor: 2.631

Review 9.  The diagnosis and treatment of early psoriatic arthritis.

Authors:  Allen P Anandarajah; Christopher T Ritchlin
Journal:  Nat Rev Rheumatol       Date:  2009-10-06       Impact factor: 20.543

Review 10.  Psoriatic arthritis: pharmacotherapy update.

Authors:  Philip J Mease
Journal:  Curr Rheumatol Rep       Date:  2010-08       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.